Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Nationwide fined £44m for financial crime control failures

(Sharecast News) - Nationwide has been slapped with a £44m fine by the UK's financial regulator for financial crime prevention failures from October 2016 to July 2021. The Financial Conduct Authority said the building society did not have adequate systems for keeping up-to-date due diligence and risk assessments for all personal current account customers and for monitoring their transactions.

Nationwide was also aware that some of those customers were using their personal accounts for business activity, in breach of its terms, the FCA added.

As Nationwide did not at the time offer business current accounts the correct processes to manage potential financial crime risks were not in place.

"Nationwide failed to get a proper grip of the financial crime risks lurking within its customer base. It took too long to address its flawed systems and weak controls, meaning red flags were missed with serious consequences," said Therese Chambers, joint executive director of enforcement and market oversight at the FCA.

"Building societies and banks have a key role in the fight against financial crime. Firms must remain vigilant in this fight."

In one serious case, Nationwide missed opportunities to identify a customer using personal current accounts to receive fraudulent Covid furlough payments. The customer received 24 payments totalling £27.3m over 13 months, with £26.01m of this deposited over eight days.

The Revenue & Customs department recovered £26.5m, but approximately £800,000 remains outstanding.

Nationwide faced a potential penalty of nearly £63m but received a 30% reduction under the FCA's settlement procedures after agreeing to resolve the case.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
SolGold recommends revised £842m from Jiangxi Copper
(Sharecast News) - Copper-gold miner SolGold has recommended shareholders vote in favour of a revised £842m cash offer from Chinese copper giant and Jiangxi Copper Company, which has already received the support from other major shareholders.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.